Американское общество гирудотерапии

Research progress on the treatment of diabetic nephropathy with leech and its active ingredients

Comprehensive review published in Frontiers in Endocrinology (2024)

Последнее обновление: June 18, 2026Рецензент: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewФармакология секрета слюнных желёзРазработка лекарственных препаратовTian F et al. · Frontiers in endocrinology, 2024

Abstract

Diabetic nephropathy (DN) is a major microvascular complication of diabetes and a common cause of chronic kidney disease. There is currently a lack of effective treatments for DN, and the prognosis for patients remains poor. Hirudin, one of the primary active components derived from leeches, demonstrates anti-coagulant, anti-fibrotic, anti-thrombotic, and anti-inflammatory properties, exhibiting significant protective effects on the kidneys. In recent years, there has been a surge of interest in studying the potential benefits of hirudin, especially in its role in the management of DN. This article delves into the mechanisms by which hirudin contributes to the treatment of DN and its clinical efficacy.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReviewResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsHumansDiabetic NephropathiesHirudinsKidneyMedicine, Chinese TraditionalLeechesDiabetes Mellitus

Резюме

Reviews preclinical evidence for medicinal leech and its active ingredients (hirudin variants, peptides) in treatment of diabetic nephropathy across multiple animal models.

Почему это важно для гирудотерапии

This review article examines the mechanisms by which hirudin, identified as a primary active component derived from leeches with anti-coagulant, anti-fibrotic, anti-thrombotic, and anti-inflammatory properties, may contribute to the treatment of diabetic nephropathy and its clinical efficacy. It discusses the lack of effective current treatments for diabetic nephropathy and the growing interest in hirudin's renoprotective potential. For ASH's domain, this is directly relevant as it surveys hirudin's therapeutic relevance beyond anticoagulation, specifically for renal protection in diabetes. Caveat: the abstract provides no specific quantitative data, primary study results, or critical appraisal of evidence quality; as a narrative review, its conclusions cannot be independently verified from the abstract alone.

Цитирование

Research progress on the treatment of diabetic nephropathy with leech and its active ingredients.

Tian F et al. · Frontiers in endocrinology, 2024

Связанный клинический контекст

Узнайте, как это исследование связано с клинической практикой

Добавлено в библиотеку ASH: May 27, 2026 · Последнее обновление сайта: June 18, 2026

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.